Search results
Top Stock Reports for Danaher, Regeneron Pharmaceuticals & Palo Alto Networks
Zacks via Yahoo Finance· 8 hours agoToday's Research Daily features new research reports on 16 major stocks, including Danaher...
TD Cowen lifts Regeneron stock PT to $1,030 despite recent pullback By Investing.com
Investing.com· 16 hours agoOn Wednesday, TD (TSX:TD) Cowen showed confidence in Regeneron Pharmaceuticals Inc (NASDAQ:REGN),...
UBS Group Boosts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $1,099.00
ETF DAILY NEWS· 5 days agoRegeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its target price raised by UBS Group from $1,090.00 to $1,099.00 in a research note published on Wednesday, Benzinga ...
Making the Grade: 20 LI students qualify for Regeneron International Science and Engineering Fair
Newsday· 19 hours agoTwenty Long Island students have qualified for the Regeneron International Science and Engineering...
Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell...
Morningstar· 2 days agoOral presentations include updated results from clinical study of otoferlin gene therapy DB-OTO demonstrating restoration in children with profound genetic hearing loss Additional presentations ...
Regeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Caution
Simply Wall St. via Yahoo Finance· 6 days agoOver the past year, many Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) insiders sold a significant...
Greenleaf Trust Increases Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 4 days agoGreenleaf Trust raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 3.4% during the fourth quarter, according to the company in its most ...
StockNews.com Downgrades Regeneron Pharmaceuticals (NASDAQ:REGN) to Buy
ETF DAILY NEWS· 3 days agoSeveral other research analysts have also weighed in on REGN. Truist Financial restated a “buy” rating and set a $1,135.00 price objective on shares of Regeneron Pharmaceuticals ...
DOJ Files False Claims Act Complaint Against Regeneron, Alleging Fraudulent Eylea Drug Pricing | JD...
JD Supra· 3 days agoAs we previously reported, the U.S. Department of Justice (“DOJ”) filed a lawsuit under the Anti-Kickback Statute against Regeneron Pharmaceuticals in the District of Massachusetts ...
Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success
Zacks via Yahoo Finance· 6 days agoIt was a busy week in the biotech sector with lots of important regulatory and pipeline updates....